Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control - Trial NCT06151821
Access comprehensive clinical trial information for NCT06151821 through Pure Global AI's free database. This phase not specified trial is sponsored by Shifa International Hospital and is currently Completed. The study focuses on Type 1 Diabetes Mellitus. Target enrollment is 68 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shifa International Hospital
Timeline & Enrollment
N/A
Aug 01, 2023
Oct 03, 2023
Primary Outcome
Diabetes distress scale
Summary
The study aims to investigate the effects of Guided Meditation on diabetes-related distress
 and glycemic control in hospitalized Type 1 adolescent diabetic patients. The study will
 employ a randomized controlled trial design, with participants randomly assigned to either
 the intervention group (receiving Guided Meditation sessions) or the control group (receiving
 standard care). The primary outcomes measured will be diabetes-related distress levels and
 glycemic control (HbA1c levels).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06151821
Non-Device Trial